PHARMPROTECH HOLDING ApS: Financial statements 2025
CVR: 29174644
Source: annual report 2025, Danish Business Authority
01/10/2024 – 30/09/2025
PHARMPROTECH HOLDING ApS (CVR 29174644) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -767,188 and a net result of DKK 3,595,179 compared with DKK 5,877,922 the year before. Equity in the 2025 report amounted to DKK 38,132,221. The solvency ratio was 86.7%.
- Gross Profit
- DKK -767,188
- Profit/Loss
- DKK 3,595,179
- Equity
- DKK 38,132,221
- Total Assets
- DKK 43,994,599
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -767 t. | 3.6 mio. | 38.1 mio. | 0 |
| 2024 | - | -164 t. | 5.9 mio. | 34.6 mio. | - |
| 2023 | - | -17 t. | 5.2 mio. | 28.8 mio. | - |
| 2022 | - | -10 t. | 5.6 mio. | 23.6 mio. | - |
| 2021 | - | -10 t. | 1.3 mio. | 18.1 mio. | - |
Official annual report
How creditworthy is PHARMPROTECH HOLDING ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout PHARMPROTECH HOLDING ApS
PHARMPROTECH HOLDING ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2005. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Tony Christensen. The company is owned by Tony Christensen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -767,188 and a net result of DKK 3,595,179 compared with DKK 5,877,922 the year before. Equity in the 2025 report amounted to DKK 38,132,221.